Is there some kind of conspiracy against “very good” medicines which have likely to “recover” by major pharma? Are they worried it may Lower to the income of their other medication, like NSAIDs, PPIs, and biologics?Although not the principal use circumstance, BPC‑157 has also shown neuroprotective consequences in animal designs—serving